LILRB2 and acute myeloid leukemia: LILRB2 and PirB are expressed by hematopoietic stem cells (HSCs) and leukemia stem cells in humans and mice, respectively, and support the ex vivo expansion of HSCs and acute myeloid leukemia (AML) development [1, 2].